We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 1,808 results
  1. Myotonic dystrophy type 1 cosegregating with autosomal dominant polycystic kidney disease type 2

    Tommaso Nicoletti, Pietro Chiurazzi, ... Gabriella Silvestri in Neurological Sciences
    Article 25 June 2020
  2. Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis

    Background

    Cognitive impairments in patients with myotonic dystrophy type 1 (DM1) have often been described, however, there are only few studies...

    K. Gutschmidt, S. Wenninger, ... B. Schoser in Journal of Neurology
    Article Open access 26 August 2020
  3. p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome

    Introduction

    Mutations of the skeletal muscle sodium channel gene SCN4A are associated with several neuromuscular disorders including...

    Andrea Rigamonti, Vittorio Mantero, ... Andrea Salmaggi in Neurological Sciences
    Article 11 August 2021
  4. MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

    MiR-1 and myostatin are markers for muscle growth and regeneration. Myostatin has a key role in the regulation of muscle mass. Myotonic dystrophy...

    Valentina Pegoraro, Paola Cudia, ... Corrado Angelini in Neurological Sciences
    Article 29 April 2020
  5. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1

    Objective

    The objective of this longitudinal, observational study was to investigate change over time in ability to perform activities of daily living...

    Erik Landfeldt, Nikoletta Nikolenko, ... Hanns Lochmüller in Journal of Neurology
    Article Open access 15 June 2020
  6. Next generation sequencing panel as an effective approach to genetic testing in patients with a highly variable phenotype of neuromuscular disorders

    Neuromuscular disorders (NMDs) include a wide range of diseases affecting the peripheral nervous system. The genetic diagnoses are increasingly...

    Wiktoria Radziwonik-Fraczyk, Ewelina Elert-Dobkowska, ... Anna Sulek in Neurogenetics
    Article Open access 17 May 2024
  7. Swallow-related quality of life and oropharyngeal dysphagia in myotonic dystrophy

    Purpose

    This study describes swallow-related quality of life (SWAL-QOL) in patients with myotonic dystrophy type 1 (DM1) and investigates its...

    Walmari Pilz, Valéria Lima Passos, ... Laura W. J. Baijens in European Archives of Oto-Rhino-Laryngology
    Article Open access 15 April 2020
  8. Physical activity in myotonic dystrophy type 1

    Background

    Physical inactivity is associated with lifestyle diseases and exercise of moderate intensity seems beneficial in DM1, but knowledge about...

    Kirsten Lykke Knak, Aisha Munawar Sheikh, ... John Vissing in Journal of Neurology
    Article 17 February 2020
  9. Myocardial native T1 map** and extracellular volume quantification in asymptomatic female carriers of Duchenne muscular dystrophy gene mutations

    Background

    Female carriers of dystrophin gene mutations (DMD-FC) were previously considered non-manifesting, but in recent decades, cardiomyopathy...

    Lucia Masárová, Roman Panovský, ... Věra Feitová in Orphanet Journal of Rare Diseases
    Article Open access 11 September 2023
  10. Myotonic dystrophy type 1 accompanied with normal pressure hydrocephalus: a case report and literature review

    Background

    Myotonic dystrophy type 1 (DM1) is the most common disease that can cause muscle weakness and atrophy among adults. Normal pressure...

    Junyang Wang, Ming Liu, ... Guo** Peng in BMC Neurology
    Article Open access 12 February 2020
  11. Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy

    Background

    Facioscapulohumeral dystrophy (FSHD) is a major muscular dystrophy characterized by asymmetric fatty replacement of muscles. We aimed to...

    Linda Heskamp, Augustin Ogier, ... Arend Heerschap in Communications Medicine
    Article Open access 01 December 2022
  12. Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy

    Background

    Fuchs endothelial corneal dystrophy is a hereditary disease and the most frequent cause of corneal transplantation in the worldwide. Its...

    Xuerui Liu, Tao Zheng, ... ** Liu in Eye and Vision
    Article Open access 15 June 2021
  13. Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature

    Background

    Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction...

    Sarah C. Sasson, Alastair Corbett, ... Sandhya Limaye in Journal of Medical Case Reports
    Article Open access 20 November 2019
  14. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

    Background

    The Limb Girdle Muscular Dystrophies (LGMDs) are characterized by progressive weakness of the shoulder and hip girdle muscles as a result...

    Amy Doody, Lindsay Alfano, ... Stacy Dixon in BMC Neurology
    Article Open access 15 March 2024
  15. A 20-year bibliometric analysis of Fuchs endothelial corneal dystrophy: from 2001 to 2020

    Purpose

    The aim of this study was to identify trends and focuses in the field of Fuchs endothelial corneal dystrophy (FECD) research.

    Methods ...
    Feng Lin, Luoli Zhang, ... **ngtao Zhou in BMC Ophthalmology
    Article Open access 08 June 2022
  16. Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis

    Background

    The rare nature of dystrophic and non-dystrophic myotonia has limited the available evidence on the efficacy of mexiletine as a potential...

    Abdelrahman Mohammed Elettreby, Ahmed Abdullah Abo Elnaga, ... Gehad Magdy Alderbi in Neurological Sciences
    Article 26 February 2024
  17. Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case–control study

    Purpose

    Myotonic dystrophy type 1 (DM1) is a genetic disorder caused by CTG expansion in the DMPK gene. The aim was to investigate the endocrine and...

    M. Spaziani, A. Semeraro, ... A. F. Radicioni in Journal of Endocrinological Investigation
    Article 30 November 2019
  18. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1

    Objective

    Daytime sleepiness and fatigue are prominent symptoms of myotonic dystrophy type I (DM1) that exact a heavy toll on patients’ quality of...

    Luc Laberge, Benjamin Gallais, ... Cynthia Gagnon in Journal of Neurology
    Article 31 October 2019
  19. Investigation of surface electromyography amplitude values during stair climbing task in children with Duchenne muscular dystrophy

    Objective

    The aims of this study were (a) to examine the surface electromyography (sEMG) amplitude values of the lower limb muscles during stair...

    Merve Bora, Ali Yalçin, ... İpek Alemdaroğlu-Gürbüz in Neurological Sciences
    Article 04 October 2021
Did you find what you were looking for? Share feedback.